NCT06424275Enrolling by invitation
Prostate Cancer Awareness and Initiative for Screening in the European Union
Source: ClinicalTrials.gov · Last updated 15 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
PRAISE-U was initiated on the 1st of April 2023 and is set to last for three years. This collaborative effort involves 25 institutions across 12 countries, all driven by a shared objective: to rationalize prostate cancer screening in Europe and enhance patient outcomes. PRAISE-U advocates for EU member states to offer exceptional clinical standards, incorporating cutting-edge personalized approaches to enable timely detection of prostate cancer in individuals who can benefit from early treatment. To assess the functionality, feasibility, and long-term viability of a risk-based algorithm, the consortium will collaborate with pilot sites in Spain, Poland, Ireland, and Lithuania.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 20000 (estimated)
- First submitted
- 16 May 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 1 Apr 2026
- Lead sponsor
- European Association of Urology Research Foundation
- Diseases
- Prostate cancer
- NCT number
- NCT06424275
What you commit to
- Study type: Observational
- Planned participants: 20000
- From 1 Jun 2024 to the primary completion date, 1 Apr 2026
- 5 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous diagnosis of prostate cancer.
Other
- Unable to provide written informed consent.
- Had prostate biopsy or MRI within the past six months.
Who the study is looking for
- Age 50-69 years old.
Age in the registry: 50 years to 69 years · Sex: Male · Accepts healthy volunteers
Sites (5)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Althaia Foundation Coordinator of this site? Confirm its status | Manresa | Spain | Unknown status |
| Public Health Directorate, SERGAS Coordinator of this site? Confirm its status | Santiago de Compostela | Spain | Unknown status |
| University College Dublin Coordinator of this site? Confirm its status | Dublin | Ireland | Unknown status |
| National Cancer Institute Coordinator of this site? Confirm its status | Vilnius | Lithuania | Unknown status |
| Lower Silesian Oncology, Pulmonology and Hematology Center Coordinator of this site? Confirm its status | Wroclaw | Poland | Unknown status |
Related publications
- Mapping the readiness landscape for prostate cancer screening in Europe: analysis of health system capacity across the PRAISE-U pilots.EClinicalMedicine · 2026 · PMID 42802883
This page is information, not medical advice. Discuss any trial with your doctor.